1. Home
  2. HOUR vs BDSX Comparison

HOUR vs BDSX Comparison

Compare HOUR & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hour Loop Inc.

HOUR

Hour Loop Inc.

HOLD

Current Price

$1.91

Market Cap

66.8M

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$17.26

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOUR
BDSX
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.8M
122.0M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
HOUR
BDSX
Price
$1.91
$17.26
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
10.9K
153.6K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
128.57
N/A
EPS
0.07
N/A
Revenue
$138,252,861.00
$88,499,000.00
Revenue This Year
N/A
$23.35
Revenue Next Year
N/A
$19.33
P/E Ratio
$27.14
N/A
Revenue Growth
4.64
24.08
52 Week Low
$1.10
$0.25
52 Week High
$6.84
$20.21

Technical Indicators

Market Signals
Indicator
HOUR
BDSX
Relative Strength Index (RSI) 55.12 62.47
Support Level $1.75 $6.33
Resistance Level $1.95 N/A
Average True Range (ATR) 0.04 1.84
MACD -0.00 0.20
Stochastic Oscillator 35.03 65.98

Price Performance

Historical Comparison
HOUR
BDSX

About HOUR Hour Loop Inc.

Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: